Navin Molecular, a CDMO headquartered in India with small molecule development and manufacturing capabilities, is investing $1.2 million to construct a new 1,200-square-meter R&D facility at its site in Dewas, India. The new facility will increase the capacity for laboratory- and kilo-scale process development, as well as enhance analytical development and testing capabilities to support the development and scale up of customer projects. The new building will have 48 fume hoods for chemic...